CCP
JAZZ icon

Cardan Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cardan Capital Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.67M Sell
20,543
-239
-1% -$36.1K 0.3% 86
2021
Q2 		$3.69M Sell
20,782
-310
-1% -$53.7K 0.41% 78
2021
Q1 		$3.47M Buy
21,092
+432
+2% +$71.1K 0.42% 76
2020
Q4 		$3.41M Sell
20,660
-31
-0.1% -$4.62K 0.42% 74
2020
Q3 		$2.95M Buy
20,691
+933
+5% +$116K 0.39% 87
2020
Q2 		$2.18M Buy
19,758
+132
+0.7% +$14.6K 0.31% 99
2020
Q1 		$1.96M Sell
19,626
-485
-2% -$62.7K 0.33% 80
2019
Q4 		$3M Buy
20,111
+297
+1% +$40.4K 0.4% 68
2019
Q3 		$2.54M Buy
19,814
+961
+5% +$129K 0.36% 69
2019
Q2 		$2.69M Buy
18,853
+683
+4% +$91.8K 0.41% 68
2019
Q1 		$2.6M Sell
18,170
-81
-0.4% -$10.6K 0.42% 65
2018
Q4 		$2.26M Buy
18,251
+258
+1% +$38.3K 0.4% 65
2018
Q3 		$3.02M Sell
17,993
-49
-0.3% -$8.43K 0.47% 59
2018
Q2 		$3.11M Buy
18,042
+142
+0.8% +$23.2K 0.51% 55
2018
Q1 		$2.7M Buy
17,900
+241
+1% +$35.4K 0.45% 58
2017
Q4 		$2.38M Sell
17,659
-1
-0% -$139 0.45% 61
2017
Q3 		$2.58M Buy
17,660
+242
+1% +$36.6K 0.52% 58
2017
Q2 		$2.71M Sell
17,418
-522
-3% -$79.8K 0.53% 57
2017
Q1 		$2.6M Sell
17,940
-219
-1% -$28.5K 0.54% 59
2016
Q4 		$1.98M Sell
18,159
-17
-0.1% -$1.89K 0.44% 65
2016
Q3 		$2.21M Buy
18,176
+102
+0.6% +$13.7K 0.49% 59
2016
Q2 		$2.55M Sell
18,074
-335
-2% -$49.4K 0.63% 51
2016
Q1 		$2.4M Buy
18,409
+6,566
+55% +$817K 0.6% 53
2015
Q4 		$1.67M Buy
+11,843
New +$1.64M 0.71% 51

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Cardan Capital Partners's JAZZ Position: Q3 2021 in Review

Cardan Capital Partners reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.2% in Q3 2021, selling an estimated $36.1K and leaving 20,543 shares worth $2.67M. The position accounts for 0.3% of the portfolio, ranked #86.

Cardan Capital Partners first reported a position in JAZZ in Q4 2015 and has held it in 24 quarters since. The position peaked at $3.69M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

  • Cardan Capital Partners held 20,543 shares of Jazz Pharmaceuticals worth $2.67M as of Q3 2021.
  • Cardan Capital Partners sold 239 Jazz Pharmaceuticals shares in Q3 2021, an estimated $36.1K.
  • Jazz Pharmaceuticals made up 0.3% of Cardan Capital Partners's portfolio in Q3 2021, its #86 holding.
  • Cardan Capital Partners first reported a position in Jazz Pharmaceuticals in Q4 2015 and has held it in 24 quarters since.
  • Cardan Capital Partners's Jazz Pharmaceuticals position peaked at $3.69M in Q2 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.